bioMérieux: CE marking for tuberculosis test
(CercleFinance.com) - On the World tuberculosis day, bioMérieux announces the CE marking of VIDAS TB IGRA, its "Fully-automated test VIDAS® TB IGRA (Interferon-Gamma Release Assay) to diagnose latent TB infection".
"With 10 million new active cases and 1.4 million related deaths worldwide in 20191, TB remains an important cause of mortality from a single infectious disease", the in-vitro diagnostics specialist said.
VIDAS TB-IGRA will be gradually rolled out in countries that recognise the CE mark. Laboratories will be able to perform these tests on the VIDAS 3 system. bioMérieux plans to submit an application for approval to the FDA in the near future.
Copyright (c) 2021 CercleFinance.com. All rights reserved.
"With 10 million new active cases and 1.4 million related deaths worldwide in 20191, TB remains an important cause of mortality from a single infectious disease", the in-vitro diagnostics specialist said.
VIDAS TB-IGRA will be gradually rolled out in countries that recognise the CE mark. Laboratories will be able to perform these tests on the VIDAS 3 system. bioMérieux plans to submit an application for approval to the FDA in the near future.
Copyright (c) 2021 CercleFinance.com. All rights reserved.